Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFLECT: Fluoxetine in Refractory Constipation with Somatic Symptom Disorder
NCT06506136Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fluoxetine in constipation. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
fluoxetine
03
Conditions
constipation
Beyond the preview
Go deeper on NCT06506136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06506136.